<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05044689</url>
  </required_header>
  <id_info>
    <org_study_id>ERC/2018/06/01</org_study_id>
    <nct_id>NCT05044689</nct_id>
  </id_info>
  <brief_title>Case Control Study to Identify Modifiable Risk Factors for Colorectal and Breast Cancer in Nigeria</brief_title>
  <official_title>Case Control Study to Identify Modifiable Risk Factors for Colorectal and Breast Cancer in Nigeria</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Obafemi Awolowo University Teaching Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Memorial Sloan Kettering Cancer Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lagos State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Ilorin Teaching Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Federal Medical Center, Owo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Obafemi Awolowo University Teaching Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project is a case-control study which seeks to identify modifiable risk factors for&#xD;
      breast and colorectal cancer in Nigeria. Both cases and controls will be required to complete&#xD;
      a risk factor questionnaire which contains information about their diet, physical activity,&#xD;
      past medical history and life style factors. They will also be required to provide&#xD;
      information on their body composition through the use of a bioimpedance machine which&#xD;
      measures the body mass index, fat and total body water percentage.&#xD;
&#xD;
      Based on the existing ARGO platform where a current colorectal cancer study is going on,&#xD;
      approximately 400 patients with a prior diagnosis or a new diagnosis will be recruited into&#xD;
      this study. Comparatively, we will select our 400 controls from two groups of participants&#xD;
      who are free of cancer and gastrointestinal diseases.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 12, 2018</start_date>
  <completion_date type="Anticipated">April 12, 2024</completion_date>
  <primary_completion_date type="Anticipated">April 12, 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Development and Validation of Questionnaire For Assessing Modifiable Risk Factors for Cancer in Sub-Saharan Africa</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Determination of Novel Modifiable Cancer Risk Factors in a Nigerian Population</measure>
    <time_frame>2 years</time_frame>
    <description>We will determine the presence of established, plausible, and novel cancer risk factors in cases (n=400) and controls (n=400) in Nigeria</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Colorectal Cancer</condition>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Colorectal Cancer (Cases)</arm_group_label>
    <description>Based on the existing ARGO (African Colorectal Cancer Group) platform where a current colorectal cancer study is going on, 400 patients with a prior diagnosis and a new diagnosis will be recruited into this study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <description>We will select our 400 controls from two groups of participants who are free of cancer and gastrointestinal diseases. First, we will leverage community mobilization groups to identify and recruit a target group of 200 community-based population controls. Second, we will identify and recruit the remaining 200 controls from those seeking care in the Outpatient Health Center at OAU, which sees ~50-60 patients per day as part of routine care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Questionnaire</intervention_name>
    <description>Questionnaire containing questions regarding diet, physical activity, past medical history and life style practices.</description>
    <arm_group_label>Colorectal Cancer (Cases)</arm_group_label>
    <arm_group_label>Controls</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bioimpedance/Body Composition Unit</intervention_name>
    <description>Patients will provide information on body composition through the use of a bioimpedance machine which measures the body mass index, fat and total body water.</description>
    <arm_group_label>Colorectal Cancer (Cases)</arm_group_label>
    <arm_group_label>Controls</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Based on the existing African Research Group for Oncology platform where a current&#xD;
        colorectal study is going on, 400 patients with a prior diagnosis and a new diagnosis of&#xD;
        colorectal cancer or breast cancer will be recruited into this study.&#xD;
&#xD;
        A combined total of 400 controls will be recruited from community mobilization groups and&#xD;
        the Outpatient Health Center at OAU who are free of cancer and gastrointestinal diseases.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Case Group - Patients must have histologically confirmed diagnosis of colorectal or breast&#xD;
        cancer.&#xD;
&#xD;
        Control Group - Patients must not have a diagnosis of cancer.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Obafemi Awolowo University Teaching Hospitals</name>
      <address>
        <city>Ile Ife</city>
        <state>Osun</state>
        <zip>220005</zip>
        <country>Nigeria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olusegun I Alatise, FWACS</last_name>
      <phone>2348033859387</phone>
      <email>segunalatishe@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Nigeria</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 9, 2021</study_first_submitted>
  <study_first_submitted_qc>September 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2021</study_first_posted>
  <last_update_submitted>September 9, 2021</last_update_submitted>
  <last_update_submitted_qc>September 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Obafemi Awolowo University Teaching Hospital</investigator_affiliation>
    <investigator_full_name>Olusegun Alatise</investigator_full_name>
    <investigator_title>MB.ChB (Ife), M.Sc, FWACS, FMCS, FACS</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

